These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 27271369)
41. In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug Interactions. Filppula AM; Mustonen TM; Backman JT Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):739-748. PubMed ID: 29956478 [TBL] [Abstract][Full Text] [Related]
42. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib. Uttamsingh V; Lu C; Miwa G; Gan LS Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134 [TBL] [Abstract][Full Text] [Related]
43. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process. Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430 [TBL] [Abstract][Full Text] [Related]
44. Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes. Liu X; Wang Q; Chen M; Tao J; Wang J; Liu S; Hou J; Li D; Wang R J Ethnopharmacol; 2023 May; 308():116303. PubMed ID: 36841379 [TBL] [Abstract][Full Text] [Related]
45. Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone. Chen Y; Mao J; Hop CE Drug Metab Dispos; 2015 Feb; 43(2):182-9. PubMed ID: 25324279 [TBL] [Abstract][Full Text] [Related]
46. Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities. Jiang K; Li K; Qin F; Lu X; Li F Toxicol In Vitro; 2011 Aug; 25(5):1033-8. PubMed ID: 21466844 [TBL] [Abstract][Full Text] [Related]
47. Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19. Kaartinen TJK; Tornio A; Tapaninen T; Launiainen T; Isoherranen N; Niemi M; Backman JT Clin Pharmacol Ther; 2020 Dec; 108(6):1254-1264. PubMed ID: 32558923 [TBL] [Abstract][Full Text] [Related]
48. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes. Emoto C; Iwasaki K Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. Grimm SW; Dyroff MC Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of genipin on human cytochrome P450 isoenzymes and P-glycoprotein in vitro. Gao LN; Zhang Y; Cui YL; Yan K Fitoterapia; 2014 Oct; 98():130-6. PubMed ID: 25073096 [TBL] [Abstract][Full Text] [Related]
51. Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. Sager JE; Lutz JD; Foti RS; Davis C; Kunze KL; Isoherranen N Clin Pharmacol Ther; 2014 Jun; 95(6):653-62. PubMed ID: 24569517 [TBL] [Abstract][Full Text] [Related]
52. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro. Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C Toxicol In Vitro; 2011 Dec; 25(8):1828-33. PubMed ID: 22001672 [TBL] [Abstract][Full Text] [Related]
53. Silybin is metabolized by cytochrome P450 2C8 in vitro. Jancová P; Anzenbacherová E; Papousková B; Lemr K; Luzná P; Veinlichová A; Anzenbacher P; Simánek V Drug Metab Dispos; 2007 Nov; 35(11):2035-9. PubMed ID: 17670841 [TBL] [Abstract][Full Text] [Related]
54. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes. Faisal Z; Mohos V; Fliszár-Nyúl E; Valentová K; Káňová K; Lemli B; Kunsági-Máté S; Poór M Biomed Pharmacother; 2021 Jun; 138():111459. PubMed ID: 33706132 [TBL] [Abstract][Full Text] [Related]
55. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors. Murray M; Zhang WV; Edwards RJ Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491 [TBL] [Abstract][Full Text] [Related]
56. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602 [TBL] [Abstract][Full Text] [Related]
57. Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol. Beers JL; Fu D; Jackson KD Drug Metab Dispos; 2021 Oct; 49(10):882-891. PubMed ID: 34330718 [TBL] [Abstract][Full Text] [Related]
58. Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity. De Bock L; Boussery K; Colin P; De Smet J; T'jollyn H; Van Bocxlaer J Talanta; 2012 Jan; 89():209-16. PubMed ID: 22284482 [TBL] [Abstract][Full Text] [Related]
59. 3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction. Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB Clin Pharmacol Ther; 2023 Jun; 113(6):1284-1294. PubMed ID: 36906857 [TBL] [Abstract][Full Text] [Related]
60. Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method. Kang D; Geng T; Lian Y; Li Y; Ding G; Huang W; Ma S; Wang Z; Ma Z; Xiao W Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27891633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]